{"url_path":"/sec/wgs/8-k/2026-06-23/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/1818331/0001628280-26-044806-index.html","accession_number":"0001628280-26-044806","cik":"0001818331","ticker":"WGS","issuer_name":"GeneDx Holdings Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1818331/0001628280-26-044806-index.html","primary_entity_key":"0001818331","primary_entity_name":"GeneDx Holdings Corp."},"word_count":370,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 18, 2026, GeneDx Holdings Corp., a Delaware corporation (the “Company”), held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders (the “Stockholders”) considered and voted on the matters listed below. The proposals are described in detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 30, 2026.\n\nThere were 29,675,547 shares of the Class A common stock issued and outstanding on April 20, 2026, the record date for the Annual Meeting. The Stockholders voted on the following proposals at the Annual Meeting, each of which was approved.\n\nThe final voting results from the Annual Meeting are set forth below.\n\n(1)Proposal No. 1 — The Class II Director Election Proposal — To elect one Class II director of the Company, to serve a three-year term expiring at the Company’s 2029 annual meeting of stockholders and until such director’s successor is duly elected and qualified or until such director’s earlier death, resignation, disqualification or removal:\n\nNomineeVotes ForVotes WithheldBroker Non-Votes\n\nKatherine Stueland18,325,8945,893,4663,409,327\n\n(2)Proposal No. 2 — The Auditor Ratification Proposal — To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:\n\nVotes ForVotes AgainstAbstentions\n\n27,466,639158,8843,164\n\n(3)Proposal No. 3 — The Advisory Vote on Executive Compensation of Named Executive Officers Proposal — To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement:\n\nVotes ForVotes AgainstAbstentions\n\n22,705,9461,471,59341,821\n\n(4)Proposal No. 4 — The Advisory Vote on Frequency of Future Advisory Votes on the Compensation of Named Executive Officers Proposal — To indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years:\n\n1 Year2 Years3 YearsAbstentions\n\n23,816,12124,246358,01720,976\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nGENEDX HOLDINGS CORP.\n\nDate: June 23, 2026By:/s/ Katherine Stueland\n\nName:Katherine Stueland\n\nTitle:Chief Executive Officer"}